Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Mol Endocrinol. 2013 Apr 23;50(3):361–374. doi: 10.1530/JME-12-0154

Figure 3.

Figure 3

13cRA mediates early phosphorylation of ERK1/2. (A) Western blot analysis of phospho-MAPK relative to total-MAPK after treatment with 25 μM 13cRA at indicated times. (B) Immunofluorescent microscopy time-course directed against phospo-MAPK after treatment to 25 μM 13cRA at indicated times. Anti-phospho ERK1/2 labeled with FITC (green) and nuclei stained with DAPI.